Vitamin Shoppe Inc (NYSE:VSI) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totalling 6,548,700 shares, an increase of 10.3% from the May 30th total of 5,935,200 shares. Based on an average daily trading volume, of 561,400 shares, the short-interest ratio is presently 11.7 days. Currently, 33.6% of the company’s shares are sold short.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. RMB Capital Management LLC acquired a new stake in shares of Vitamin Shoppe during the fourth quarter worth about $483,000. Macquarie Group Ltd. raised its position in shares of Vitamin Shoppe by 114.0% during the fourth quarter. Macquarie Group Ltd. now owns 10,136 shares of the specialty retailer’s stock worth $48,000 after purchasing an additional 5,400 shares during the period. Investors Research Corp acquired a new stake in shares of Vitamin Shoppe during the first quarter worth about $34,000. FMR LLC raised its position in shares of Vitamin Shoppe by 1.3% during the fourth quarter. FMR LLC now owns 1,645,611 shares of the specialty retailer’s stock worth $7,800,000 after purchasing an additional 20,848 shares during the period. Finally, Two Sigma Advisers LP raised its position in shares of Vitamin Shoppe by 10.8% during the fourth quarter. Two Sigma Advisers LP now owns 180,743 shares of the specialty retailer’s stock worth $857,000 after purchasing an additional 17,550 shares during the period. 88.98% of the stock is currently owned by institutional investors.
Shares of VSI opened at $4.20 on Tuesday. The company has a debt-to-equity ratio of 2.36, a quick ratio of 0.16 and a current ratio of 1.14. Vitamin Shoppe has a 1 year low of $3.32 and a 1 year high of $13.95. The company has a market capitalization of $101.49 million, a PE ratio of 16.15 and a beta of 1.66. The stock’s 50-day moving average is $3.88.
A number of brokerages have issued reports on VSI. Jefferies Financial Group reduced their target price on Huntsman from $33.00 to $30.00 and set a “buy” rating on the stock in a report on Monday, June 17th. Zacks Investment Research upgraded Vistra Energy from a “hold” rating to a “buy” rating and set a $25.00 target price on the stock in a report on Saturday. Finally, ValuEngine cut Zumiez from a “hold” rating to a “sell” rating in a report on Tuesday, July 2nd. One research analyst has rated the stock with a sell rating and four have issued a hold rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $7.92.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Featured Article: Investing strategies using the yield curve
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.